(Q43681721)

25 November 2017

Chemically induced rat mammary tumor treated with tamoxifen showed decreased expression of cyclin D1, cyclin E, and p21(Cip1). (English)

1 reference

25 November 2017

1 reference

Jang TJ

1

1 reference

25 November 2017

Park JH

series ordinal

2

1 reference

25 November 2017

Cho MY

series ordinal

3

1 reference

25 November 2017

Kim JR

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

25 November 2017

8

1 reference

inferred from page(s)

published in

Cancer Letters

1 reference

25 November 2017

170

1 reference

25 November 2017

2

1 reference

25 November 2017

109-116

1 reference

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Endocrine pharmacology of antiestrogens as antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Estrogen receptor-mediated direct and indirect antitumor effects of tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Alternative mechanisms of action of anti-oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Increased expression of cyclin D1, cyclin E and p21(Cip1) associated with decreased expression of p27(Kip1) in chemically induced rat mammary carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Redundant cyclin overexpression and gene amplification in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor beta1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900593-6

7 January 2021

10.1016/S0304-3835(01)00593-6

Identifiers

DOI

1 reference

25 November 2017

1 reference